Clinical Trials

39 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07163507 2026-03-18

RICEPS-2

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07169617 2026-03-18

Testing the SurVaxM Vaccine for Lung Cancer Prevention

80 enrolled

Lung Neoplasms

NCT07328490 2026-03-18

Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

120 enrolled

Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT07328503 2026-03-18

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07332507 2026-03-18

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

30 enrolled

Plasmablastic Lymphoma

NCT07416188 2026-03-18

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

40 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

NCT07422363 2026-03-18

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

30 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT07437963 2026-03-18

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

76 enrolled

CNS

Neuroblastoma, Ganglioneuroblastoma

NCT07444710 2026-03-18

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

16 enrolled

Phase 2/3 Not yet recruiting

Ann Arbor Stage II Mantle Cell Lymphoma

NCT07444723 2026-03-18

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

193 enrolled

EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

NCT07463807 2026-03-18

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

162 enrolled

Plasma cell

Multiple Myeloma

NCT07464236 2026-03-18

PEACHES 2

8 enrolled

Anus Neoplasms, Chlamydia Infections, Gonorrhea

NCT07470268 2026-03-18

HY-PANC

10 enrolled

Motor Activity, Pancreatic Neoplasms

NCT07472933 2026-03-18

Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies

44 enrolled

Cancer of Biliary Duct

NCT07478848 2026-03-18

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

14 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07478952 2026-03-18

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

Phase 3 Not yet recruiting

120 enrolled

Epstein-Barr Virus Infections

NCT07478991 2026-03-18

VENP-A-QUI

376 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07479199 2026-03-18

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

70 enrolled

Neoplasms, Pain, Thoracic Neoplasms

NCT07479381 2026-03-18

CLEAR

1,450 enrolled

Disease, Neoplasms, Colorectal Neoplasms

NCT07479407 2026-03-18

PREHAB

74 enrolled

Carcinoma, Non-Small-Cell Lung, Postoperative Complications

NCT07479446 2026-03-18

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

174 enrolled

CNS

Neuroma, Acoustic, Postoperative Nausea and Vomiting

NCT07479472 2026-03-18

YOGICO

150 enrolled

Early-onset Gastrointestinal Cancer

NCT07479485 2026-03-18

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

160 enrolled

Carcinoma, Hepatocellular

NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

31 enrolled

Thymoma

NCT07479979 2026-03-18

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

62 enrolled

Plasma cell

Multiple Myeloma

NCT07480005 2026-03-18

To Revisit the Yield of Staging Laparoscopy in Hepatopancreatobiliary Malignancies

350 enrolled

HPB Malignancies

NCT07480044 2026-03-18

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Phase 3 Not yet recruiting

220 enrolled

Genitourinary

Emergence Delirium, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT07480356 2026-03-18

ADVANCED-3

284 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

NCT07480681 2026-03-18

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

138 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT07480694 2026-03-18

Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADC

400 enrolled

Treatment Efficacy

NCT07480733 2026-03-18

A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors

480 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT07481032 2026-03-18

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

1,034 enrolled

Phase 3 Not yet recruiting

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT07481149 2026-03-18

EX-CIPN

240 enrolled

Peripheral Nervous System Diseases

NCT07481357 2026-03-18

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

51 enrolled

Stomach Neoplasms

NCT06726330 2026-03-17

FIMBRIMENOP

1,100 enrolled

Gynecologic

Tubo-ovarian Carcinoma

NCT07021989 2026-03-17

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

38 enrolled